Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Savage William Jacob	2. Date of Event Requiring Statement (MM/DD/YYYY) 12/29/2022	3. Issuer Name and Ticker or Trading Symbol Disc Medicine, Inc. [IRON]
(Last)        (First)        (Middle) C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Chief Medical Officer /
(Street) WATERTOWN, MA 02472       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20325	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	8/10/2030	Common Stock	20326	$2.65	D
Stock Option (Right to Buy)	(2)	10/22/2030	Common Stock	10275	$2.65	D
Stock Option (Right to Buy)	(3)	9/13/2031	Common Stock	45192	$9.86	D
Stock Option (Right to Buy)	(4)	9/13/2031	Common Stock	10521	$9.86	D

Explanation of Responses:
(1)	25% of the 40,651 shares originally underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The Reporting Person previously partially exercised this option.
(2)	2,140 shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 38 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
(3)	The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
(4)	The shares underlying this option vest in 48 equal monthly installments following July 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Savage William Jacob C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101 WATERTOWN, MA 02472			Chief Medical Officer

Signatures
/s/ Rahul Khara, attorney-in-fact		1/3/2023
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.